SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-104327
Filing Date
2021-04-02
Accepted
2021-04-01 20:12:48
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d156749ds3.htm S-3 412839
2 EX-4.14 d156749dex414.htm EX-4.14 307996
3 EX-5.1 d156749dex51.htm EX-5.1 23997
4 EX-5.2 d156749dex52.htm EX-5.2 12292
5 EX-23.3 d156749dex233.htm EX-23.3 1830
6 GRAPHIC g156749dsp1logo.jpg GRAPHIC 2288
7 GRAPHIC g156749dsp2.jpg GRAPHIC 1766
8 GRAPHIC g156749g25x78.jpg GRAPHIC 63153
  Complete submission text file 0001193125-21-104327.txt   853048
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254985 | Film No.: 21800192
SIC: 2834 Pharmaceutical Preparations